ALAlphabet Inc.
Institutional investor · Portfolio as of Q1 2024
Top Holdings43 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
GITLAB INC | 9.8M | $569.1M | 22.6% | $54.31 | +7.39% | 6 qtrssince 2022-Q4 | Increased 100 |
CROWDSTRIKE HOLDINGS INC - A | 855,789 | $274.4M | 10.9% | $120.06 | +167.02% | 6 qtrssince 2022-Q4 | Decreased 0 |
DEXCOM INC | 1.8M | $248.4M | 9.9% | $122.16 | +13.54% | 6 qtrssince 2022-Q4 | Decreased 0 |
ARM Holdings PLC Sponsored ADR | 2M | $245.1M | 9.7% | $53.52 | +133.54% | 3 qtrssince 2023-Q3 | Unchanged 0 |
FRESHWORKS INC | 12.3M | $224.7M | 8.9% | $17.07 | +6.71% | 6 qtrssince 2022-Q4 | Increased 97 |
REVOLUTION MEDICINES INC | 5.3M | $170.9M | 6.8% | $28.68 | +12.38% | 2 qtrssince 2023-Q4 | Unchanged 0 |
VERVE THERAPEUTICS INC | 12.3M | $164M | 6.5% | — | — | 6 qtrssince 2022-Q4 | Unchanged 0 |
UIPATH INC | 7M | $159.5M | 6.3% | $12.71 | +78.36% | 6 qtrssince 2022-Q4 | Unchanged 0 |
PRIME MEDICINE INC | 15.1M | $105.4M | 4.2% | $16.12 | -56.58% | 6 qtrssince 2022-Q4 | Increased 69 |
SNOWFLAKE INC-CLASS A | 535,604 | $86.6M | 3.4% | $143.54 | +12.58% | 6 qtrssince 2022-Q4 | Unchanged 0 |
PLANET LABS PBC | 31.9M | $81.5M | 3.2% | $4.35 | -41.38% | 6 qtrssince 2022-Q4 | Unchanged 0 |
SANA BIOTECHNOLOGY INC | 2.8M | $28.1M | 1.1% | $3.95 | +153.16% | 6 qtrssince 2022-Q4 | Unchanged 0 |
INVIVYD INC | 4.5M | $20.1M | 0.8% | $1.50 | -50.63% | 6 qtrssince 2022-Q4 | Decreased 0 |
LYELL IMMUNOPHARMA INC | 5.9M | $13.1M | 0.5% | — | — | — | — |
RELAY THERAPEUTICS INC | 1.6M | $13M | 0.5% | $14.94 | -44.44% | 6 qtrssince 2022-Q4 | Unchanged 0 |
BEAM THERAPEUTICS INC | 321,604 | $10.6M | 0.4% | $39.11 | -15.52% | 6 qtrssince 2022-Q4 | Unchanged 0 |
VERA THERAPEUTICS INC | 241,264 | $10.4M | 0.4% | $19.35 | +122.84% | 6 qtrssince 2022-Q4 | Decreased 0 |
MONTE ROSA THERAPEUTICS INC | 1.5M | $10.3M | 0.4% | $7.61 | -7.36% | 6 qtrssince 2022-Q4 | Unchanged 0 |
Desktop Metal Inc. | 11M | $9.7M | 0.4% | — | — | — | — |
TSCAN THERAPEUTICS INC | 1.1M | $8.6M | 0.3% | $1.55 | +412.26% | 6 qtrssince 2022-Q4 | Unchanged 0 |
Alphabet Inc. manages $2.5B across 43 positions as of Q1 2024. Top holdings: GTLB (22.6%), CRWD (10.9%), DXCM (9.9%). Fund DNA: Concentrated Value. HoldingsIntel Rating: 1.5/5.0.
Added 1 new position, exited 2, increased 3, trimmed 5. Top move: GTLB (INCREASED, conviction 100). Portfolio: $2.5B across 43 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
No active accumulation streaks detected for this filer.
Streaks require 2+ consecutive quarters of increased positions in the most recent period.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer